Brain

Meditation Improves Concentration, Says Study

Researchers at the University of Pennsylvania say that practicing even small doses of daily meditation may improve focus and performance.

Animal Study Doesn't Mean Risk For Newborns, Anesthesiologist Says

Recent studies showing that commonly used anesthetic agents can cause brain damage in animals don't prove that similar harmful effects occur in human newborns—and shouldn't affect current approaches to anesthesia in preterm and ill infants, according to a leading expert on pain management in newborns.

Is Fibromyalgia A True Medical Condition?

Fibromyalgia is a chronic, widespread pain in muscles and soft tissues accompanied by fatigue that does not manifest any structural damage in an organ.

It affects approximately 2% of the US population, is an example of a class of maladies called CSS. These diseases are based on neurochemical abnormalities and include irritable bowel syndrome, migraine and restless legs syndrome.

Twenty-five years ago, Muhammad B. Yunus, MD, and colleagues published the first controlled study of the clinical characteristics of fibromyalgia syndrome.

Omega-3 Fatty Acids Protect Against Blindness, Study Says

Increasing intake of the omega-3 fatty acids DHA and EPA, found in popular fish-oil supplements, may protect against blindness resulting from abnormal blood vessel growth in the eye, according to a study done at Children's Hospital Boston. The study was done in mice, but a clinical trial will soon begin testing the effects of omega-3 supplementation in premature babies, who are at risk for vision loss.

Study Shows Brain's Pleasure Response - And How It Can Go Wrong

We all have tastes we love, and tastes we hate. And yet, our "taste" for certain flavors and foods can change over time, as we get older or we get tired of eating the same old thing.

A University of Michigan study gives evidence about what's going on in the brain when we taste something we like, or develop a liking for something we once hated.

Alzheimer's Drug CTS-21166 Goes Into Clinical Trials

CTS-21166, an experimental drug to treat Alzheimer's disease, began the first phase of human clinical trials this week.

"Millions of people suffer from this devastating disease and treatment options are very limited," said Arun Ghosh, a Purdue professor who led the creation of the treatment molecule. "Current drugs manage the symptoms, but this could be the first disease-modifying therapy. It may be able to prevent and reverse the disease."

Arguing With Supermodels About Anorexia

Misstatements and ignorance claiming that families "cause" eating disorders is like blaming parents for diabetes or asthma or cancer says an international group of eating disorders researchers.

Recent damaging statements by fashion model Gisele Bundchen stating that unsupportive families cause anorexia nervosa only perpetuate misconceptions and further stigmatize eating disorders.

New vaccine prevents CMV Herpes virus in mice

Researchers at UCSD have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.

CMV, a type of herpes virus, is the leading viral cause of birth defects and a serious problem in patients with compromised immune systems. The body’s natural immunity doesn’t protect against infection by the virus, estimated to be present in 50 to 75 percent of all adults.

Turn-Ons And Turn-Offs For Neurons

Our brain consists of billions of nerve cells enabling to learn, remember and reason. Every time we think and experience, touch, smell or fear, millions of neurons in our brain becomes active.

These nerve cells communicate with each other by chemical and electrical impulses to compute incoming sensory information and integrate it via distinct brain regions. With 20,000 - 25,000 genes in our genome, most also expressed in neurons, there is now little doubt that neurons respond to challenging environments by adjusting the expression of genes for appropriate brain functions.

Writing Down Feelings Really Does Make Us Feel Better, Study Says

Why does putting our feelings into words — talking with a therapist or friend, writing in a journal — help us to feel better? A new brain imaging study by UCLA psychologists reveals why verbalizing our feelings makes our sadness, anger and pain less intense.

"Brain Machine" Technology Brings Remote Control To The Next Level

From the viewpoint of biology, learning and education can be defined as the processes of forming neuronal connections in response to external environmental stimuli, and of controlling or adding appropriate stimuli, respectively.

Computers can't do that but researchers in Japan have shown how they can control electronic devices simply by reading brain activity.

The "brain-machine" developed by Hitachi Inc. recently analyzed changes in the Akiko Obata's blood flow and translated those into electric signals which linked to a mapping device that controlled a toy train.

Bullseye On Cancer: Hunter-Killer Nanoparticles Target Cancer Cells

Nanobiotechnology holds a lot of promise and people have often speculated how it will impact the world of medicine. Unfortunately promising nanostructured systems so far have turned out to be extremely toxic to humans.

Measuring self-assembly in action

By making careful observations of the growth of a layer of molecules as they gradually cover the surface of a small silicon rectangle, researchers from the National Institute of Standards and Technology (NIST) and North Carolina State University (NCSU) have gained basic insights into how self-propagating self-assembly wave fronts develop and have produced the first experimental verification of recently improved theoretical models of such systems.

The Brain Scope - Seeing The Brain In 3-D

Biomedical engineers at Duke's Pratt School of Engineering have adapted a three-dimensional ultrasound scanner that might guide minimally invasive brain surgeries and provide better detection of a brain tumor’s location.

The “brain scope,” which is inserted into a dime-sized hole in the skull, may be particularly useful for the bedside evaluation of critically ill patients when computed tomography (CT) and magnetic resonance imaging (MRI) equipment is unavailable, the researchers said.

Toward A Vaccine For Alzheimer's Disease

Scientists have provided new details about how proteins used to destroy bacteria and viruses may help treat Alzheimer’s disease. Gunnar K. Gouras, associate professor of neurology and neuroscience at Weill Medical College of Cornell University, New York, and colleagues provide new insights into how these proteins, called antibodies, reduce the main hallmarks of Alzheimer’s disease and raise hopes for a vaccine against the disease.